HTA Submissions and Global Value Dossiers
A health technology assessment is where all your evidence is judged at once, clinical, economic, and humanistic, against the alternatives. A global value dossier is the document that brings that evidence together into one coherent, payer-ready story. EvySaif prepares value dossiers and HTA submission support that turn scattered evidence into a clear case for value and access.
One coherent value story
A strong value dossier does not just collect evidence, it argues a case. Because the economic evaluation, budget impact, and evidence synthesis that sit beneath the dossier are all services we deliver, the dossier is built on a consistent evidence base rather than stitched together from disconnected pieces.
Assemble the evidence
Disease burden, unmet need, clinical evidence, economic model results, and real-world data are pulled together into one structured evidence base.
Argue the case
The dossier is built around a clear value proposition payers can act on, with disease-burden and unmet-need narratives that set up the case rather than pad it.
Build the global dossier
The structured global value dossier becomes the core source for every market, with payer-facing value summaries and objection handlers built from it.
Adapt to each market
From that core, we support local HTA submissions and adapt the messaging and inputs to each market's requirements, across India, the EU, and the GCC, where payers are formalising HTA and economic evaluation requirements.
Why this matters now: Gulf payers are formalising HTA and economic evaluation requirements, so a credible value story is becoming a condition of access rather than a nice-to-have.
What we prepare
Global value dossiersWith value proposition development.
HTA submission supportIncluding local adaptation per market.
Payer materialsPayer-facing value summaries and objection handlers.
Evidence integrationCEA, budget impact, SLR, and RWE woven into one narrative.
Disease narrativesDisease-burden and unmet-need narratives.
Market adaptationMarket-specific adaptation for India, the EU, and the GCC.
How EvySaif helps
We pull the disease burden, unmet need, clinical evidence, economic model results, and real-world data into a structured global value dossier with a clear value proposition, then support local HTA submissions and adapt the messaging and inputs to each market.
Why EvySaif
EvySaif stands among the best research and medical writing consultancies in India. Because we build the underlying economics, evidence synthesis, and real-world evidence ourselves, the value dossier we assemble is internally consistent, the model results match the narrative, and the evidence base matches the claims. The writing is clinician-led and the case is argued, not merely described.
Frequently asked questions
A structured document that consolidates the clinical, economic, and humanistic evidence for a product into one value story, used as the core source for local payer and HTA submissions.
Yes. We build the global core dossier and adapt the evidence, inputs, and messaging to specific markets, including India, the EU, and the GCC.
Yes. The economic model, budget impact, systematic review, and real-world evidence underneath the dossier are all services we provide, which keeps the whole package consistent.
Have a different question?
Tell us about your product, market, and timeline, and a clinician on our team will reply with specifics rather than a sales script.
Request a proposalRelated HEOR services
Preparing for reimbursement?
Tell us about your product and target markets, and we will come back with a scoped value dossier or HTA support quote.
Request a proposal